remifentanil has been researched along with Cross Infection in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bonilla-García, JL; Cortiñas-Sáenz, M; Pozo-Gavilán, ED | 1 |
García, JLB; Gavilán, EDP; Sáenz, MC | 1 |
Di Pompeo, C; Durocher, A; Grailles, G; Hoel, J; Mathieu, D; Nseir, S; Soury-Lavergne, A | 1 |
3 other study(ies) available for remifentanil and Cross Infection
Article | Year |
---|---|
Opioids and immunosupression in oncological postoperative patients.
Topics: Aged; Analgesics, Opioid; Cross Infection; Female; Humans; Immunosuppressive Agents; Male; Midazolam; Middle Aged; Neoplasms; Pain, Postoperative; Piperidines; Propofol; Remifentanil; Withholding Treatment | 2017 |
Characterization of post-surgical critical patients with infections associated with healthcare after prolonged perfusion of remifentanil.
Topics: Aged; Analgesics, Opioid; Anesthesia, Local; APACHE; Critical Illness; Cross Infection; Deep Sedation; Female; Hospitalization; Humans; Hypnotics and Sedatives; Klebsiella pneumoniae; Male; Midazolam; Middle Aged; Pneumonia, Ventilator-Associated; Postoperative Complications; Propofol; Prospective Studies; Pseudomonas aeruginosa; Remifentanil; Risk Factors; Spain; Time Factors | 2018 |
Remifentanil discontinuation and subsequent intensive care unit-acquired infection: a cohort study.
Topics: Adult; Aged; Analgesics, Opioid; Cross Infection; Female; France; Humans; Intensive Care Units; Length of Stay; Male; Middle Aged; Observation; Piperidines; Prospective Studies; Remifentanil; Risk Factors | 2009 |